It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Serious diseases such as COPD, often a combination of chronic bronchitis and emphysema caused by years of smoking, involve serious inflammation of lung tissues, and carbon monoxide appears to be able to ease this reaction, potentially improving symptoms.
The Dutch team gave 18 people a low dose of carbon monoxide for two hours on four consecutive days.
Warfarin (also known under the brand names of Coumadin, Jantoven, Marevan, and Waran) is an anticoagulant. It is named for the Wisconsin Alumni Research Foundation, which sponsored its development. It was initially marketed as a pesticide against rats and mice, and is still popular for this purpose, although more modern poisons such as brodifacoum are much more potent and toxic.
Warfarin is prescribed to people with an increased tendency for thrombosis or as prophylaxis in those individuals that have already formed a blood clot (thrombus), which required treatment. This can help prevent formation of future blood clots and help reduce the risk of embolism (migration of a thrombus to a spot where it blocks blood supply to a vital organ). Common clinical indications for warfarin use are atrial fibrillation, artificial heart valves, deep venous thrombosis, pulmonary embolism, antiphospholipid syndrome and occasionally after myocardial infarction.